Patent details

Basic Information

Publication number:

EP3802598

PCT Application Number:

EP2019064942

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP197284540

PCT Publication Number:

WO2019234220

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

DLL3/CD3 BINDING PROTEINS FOR CANCER TREATMENT

French Title of Invention:

PROTÉINES DE LIAISON DLL3/CD3 POUR LE TRAITEMENT DU CANCER

German Title of Invention:

DLL3/CD3-BINDUNGSPROTEINE ZUR KREBSBEHANDLUNG

SPC Number:

Dates

Filing date:

07/06/2019

Grant date:

12/02/2025

EP Publication Date:

14/04/2021

PCT Publication Date:

12/12/2019

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

12/02/2025

EP B1 Publication Date:

12/02/2025

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

07/06/2039

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

05/02/2025

 

 

Name:

Boehringer Ingelheim International GmbH

Address:

Binger Strasse 173, 55216 Ingelheim am Rhein, Germany (DE)

Inventor

1

Name:

GORMAN, Philip Nicholas

Address:

United States (US)

2

Name:

GUPTA, Pankaj

Address:

United States (US)

3

Name:

VOYNOV, Vladimir H.

Address:

United States (US)

4

Name:

ADAM, Paul

Address:

Germany (DE)

5

Name:

GUPTA, Priyanka

Address:

United States (US)

6

Name:

DZIEGELEWSKI, Michael

Address:

United States (US)

7

Name:

HIPP, Susanne

Address:

Germany (DE)

8

Name:

GANESAN, Rajkumar

Address:

United States (US)

9

Name:

SCHEER, Justin

Address:

United States (US)

Priority

1

Priority Number:

18176889

Priority Date:

09/06/2018

Priority Country:

European Patent Office (EPO) (EP)

2

Priority Number:

18176888

Priority Date:

09/06/2018

Priority Country:

European Patent Office (EPO) (EP)

3

Priority Number:

19159321

Priority Date:

26/02/2019

Priority Country:

European Patent Office (EPO) (EP)

Classification

IPC classification:

C07K 16/28; A61K 39/00;

Publication

European Patent Bulletin

Issue number:

202507

Publication date:

12/02/2025

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

30/06/2026

Annual Fee Number:

8

Annual Fee Amount:

99 Euro

Expected Payer:

Last Annual Fee Payment Date:

27/06/2025

Last Annual Fee Paid Number:

7

Last Annual Fee Paid Amount:

82 Euro

Payer:

DENNEMEYER & CO

Filing date	Document type	Number of pages